DEVELOPMENTAL RESEARCH PROGRAM
DEVELOPMENTAL RESEARCH PROGRAM
批准号:
7976019
负责人:
ROBERT ZYGMUNT ORLOWSKI
金额:
$9.11万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-06-30
关键词:
BudgetsClinicalCollaborationsCore FacilityDevelopmentDiagnosisDiseaseEligibility DeterminationEventFosteringFundingFutureGoalsHematologic NeoplasmsInstitutionMethodsMissionMonitorMultiple MyelomaPeer ReviewProceduresProcessProgram Research Project GrantsProgram ReviewsProgress ReportsReproduction sporesRequest for ApplicationsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesReview CommitteeScientistSeedsSourceSpecific qualifier valueStagingTestingTranslational ResearchUnited States National Institutes of Healthflexibilityinnovationinterestmeetingsmembermultidisciplinarynovelnovel strategiespreventprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Developmental Research Program (DRP) will provide seed funding to meritorious translational projects
that have the potential for significantly advancing our ability to prevent, detect, diagnose, stage, or treat
multiple myeloma. Project proposals will be selected in a rigorous, peer-reviewed, two-tiered process,
starting with a once-yeariy request for applications that will be communicated to investigators at all three
participafing institutions. In this first round, proposals will be limited to four pages, and required to assume
the format of an NIH R01 applicafion, incorporafing specific aims, background and significance, preliminary
studies, and research design and methods. These proposals will be reviewed by the DRP Director and Co-
Director to identify those that meet the pre-specified eligibility criteria, and these will be invited to submit a
full, ten-page applicafion, using the same format with the inclusion of a budget and justification. During this
second fier, proposals will be reviewed by the DRP Review Committee, which will include Leaders and/or
Co-Leaders of each of the SPORE Projects, Directors and/or Co-Directors of SPORE Cores, and at least
four members of the External Scientific Advisory Board, and four members of the Internal Scientific Advisory
Board. Up to four projects each year will be selected for funding and supported for one year, during which
progress reports will be monitored every six months. Renewal of support may be possible for a second year,
but will require the project to successfully compete with the next year's pool of proposals. Through this
mechanism, the specific aims of the DRP are: 1. To support novel, highly translational research projects
that take maximum advantage of the new research opportunities afforded by the SPORE; 2. To build and
foster new collaborafions among scientists within SPOREs, or with scienfists outside the SPORE
mechanism; and 3. To provide.scientific flexibility to the SPORE that will allow promofion of promising DRP
projects to full Project status. Prior to the submission of this applicafion, the standard operating procedure
outlined above was successfully tested, and led to the selection of several promising proposals to serve as
examples of the types of projects that would be considered for support. Notably, these come from a diverse
group of invesfigators interested in a variety of approaches with important translational implicafions, and
support the future strength of the DRP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors
-
批准号:9030014
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2016
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors
-
批准号:9204811
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2016
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
P3 - TARGETING THE HDM-2 E3 LIGASE IN MULTIPLE MYELOMA
-
批准号:7975984
-
项目类别:
-
资助金额:$17.89万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
-
批准号:8146048
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
-
批准号:8326179
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
ADMINISTRATIVE CORE FACILITY
-
批准号:7976002
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
-
批准号:7939036
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
-
批准号:8543577
-
项目类别:
-
资助金额:$215.05万
-
财政年份:2010
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA
-
批准号:7625591
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2006
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
PX-171-001-PHASE I STUDY OF ESCALATING DOSES OF PROTEASOME INHIBITOR
-
批准号:7625637
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2006
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
SB-743971 IN PATIENTS WITH NON-HODGKINS
-
批准号:7625672
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2006
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA
-
批准号:7377543
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2005
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
PX-171-001-PHASE I STUDY OF ESCALATING DOSES OF PROTEASOME INHIBITOR
-
批准号:7377585
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2005
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:7731746
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:6866567
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA
-
批准号:7200335
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:7286348
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:7027751
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:6776750
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
Dual Proteasome and MAPK Inhibition in Cancer Therapy
-
批准号:7364186
-
项目类别:
-
资助金额:$8.93万
-
财政年份:2004
-
负责人:ROBERT ZYGMUNT ORLOWSKI
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: